GSK president acquires notional ADS in savings plan
GSK plc reported an insider transaction involving President Maya Martinez-Davis.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
GSK plc reported an insider transaction involving President Maya Martinez-Davis. She acquired notional American Depositary Shares (ADS) through her GSK Executive Supplemental Savings Plan account. The plan credited 9.293 ADS at a price of $51.3800 per ADS on May 22, 2026, with the transaction executed on the New York Stock Exchange.
Key Figures
ADS volume acquired: 9.293 ADS
ADS price: $51.3800 per ADS
Transaction date: May 22, 2026
3 metrics
ADS volume acquired
9.293 ADS
Notional ADS credited to Executive Supplemental Savings Plan
ADS price
$51.3800 per ADS
Price used for the notional ADS acquisition on May 22, 2026
Transaction date
May 22, 2026
Date of notional ADS acquisition on NYSE (XNYS)
Key Terms
American Depositary Shares, Executive Supplemental Savings Plan, PDMR, LEI
4 terms
Executive Supplemental Savings Plan financial
"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"
PDMR regulatory
"Details of PDMR/person closely associated with them ('PCA')"
A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.
LEI regulatory
"b) | LEI | 5493000HZTVUYLO1D793"
A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GSK (GSK) report in this Form 6-K?
GSK reported that President Maya Martinez-Davis acquired notional American Depositary Shares through her GSK Executive Supplemental Savings Plan. The transaction involved 9.293 ADS credited at $51.3800 per ADS, reflecting a routine compensation-related acquisition rather than an open-market trade.
Who is the insider involved in the latest GSK (GSK) transaction?
The insider is Maya Martinez-Davis, a President at GSK. She received notional ADS within her GSK Executive Supplemental Savings Plan account, rather than buying shares directly on the market, as part of her executive compensation arrangements disclosed in the report.
How many GSK (GSK) ADS were acquired and at what price?
The plan credited 9.293 GSK American Depositary Shares at a price of $51.3800 per ADS. This was a single aggregated transaction recorded within the GSK Executive Supplemental Savings Plan on the New York Stock Exchange on May 22, 2026.
What type of instrument was involved in the GSK (GSK) insider transaction?
The instrument was GSK American Depositary Shares (ADS) with ISIN US37733W2044. These ADS represent an interest in GSK’s equity and were credited notionally to Maya Martinez-Davis’s Executive Supplemental Savings Plan account, rather than being directly purchased in a standard brokerage account.
Where and when was the GSK (GSK) insider transaction executed?
The transaction took place on the New York Stock Exchange (XNYS) on May 22, 2026. GSK’s filing reports this as a single transaction in which notional ADS were acquired within an executive supplemental savings plan, rather than multiple trades spread across different venues.
Is the GSK (GSK) insider transaction part of an executive compensation plan?
Yes. The filing states it is an acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account. This indicates the transaction is compensation-related, aligning with structured benefit arrangements rather than discretionary open-market share purchases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates